- Home
- LTRX vs XBIT Comparison
LTRX vs XBIT Comparison
Compare LTRX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRX
- XBIT
- Stock Information
- Founded
- LTRX 1989
- XBIT 2005
- Country
- LTRX United States
- XBIT United States
- Employees
- LTRX N/A
- XBIT N/A
- Industry
- LTRX Computer Communications Equipment
- XBIT Pharmaceuticals and Biotechnology
- Sector
- LTRX Telecommunications
- XBIT Health Care
- Exchange
- LTRX Nasdaq
- XBIT Nasdaq
- Market Cap
- LTRX 85.6M
- XBIT 86.3M
- IPO Year
- LTRX 2000
- XBIT 2015
- Fundamental
- Price
- LTRX $2.94
- XBIT $2.85
- Analyst Decision
- LTRX Strong Buy
- XBIT
- Analyst Count
- LTRX 4
- XBIT 0
- Target Price
- LTRX $4.13
- XBIT N/A
- AVG Volume (30 Days)
- LTRX 231.4K
- XBIT 43.4K
- Earning Date
- LTRX 09-04-2025
- XBIT 08-11-2025
- Dividend Yield
- LTRX N/A
- XBIT N/A
- EPS Growth
- LTRX N/A
- XBIT N/A
- EPS
- LTRX N/A
- XBIT N/A
- Revenue
- LTRX $143,159,000.00
- XBIT N/A
- Revenue This Year
- LTRX N/A
- XBIT N/A
- Revenue Next Year
- LTRX $3.66
- XBIT N/A
- P/E Ratio
- LTRX N/A
- XBIT N/A
- Revenue Growth
- LTRX N/A
- XBIT N/A
- 52 Week Low
- LTRX $1.91
- XBIT $2.50
- 52 Week High
- LTRX $4.55
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- LTRX 45.96
- XBIT 46.84
- Support Level
- LTRX $3.14
- XBIT $2.79
- Resistance Level
- LTRX $3.40
- XBIT $2.92
- Average True Range (ATR)
- LTRX 0.16
- XBIT 0.15
- MACD
- LTRX -0.04
- XBIT -0.02
- Stochastic Oscillator
- LTRX 6.12
- XBIT 17.54
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.